Maximum quantity allowed is 999
Please select the quantity
CAS RN: 84088-42-6 | Product Number: L0270
Linomide
×
![]()
×
Purity: >98.0%(HPLC)
Synonyms:
- 4-Hydroxy-N,1-dimethyl-2-oxo-N-phenyl-1,2-dihydroquinoline-3-carboxamide
- Roquinimex
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days |
|---|---|---|---|
| 10MG |
NT$10,200
|
25 | 17 |
* The above prices include freight cost, customs, and other charges to the destination except for products that need to be shipped by sea or dry ice. For details, please contact
our distributor
in Taiwan to order our product.
* The storage conditions are subject to change without notice.
| Product Number | L0270 |
| Purity / Analysis Method | >98.0%(HPLC) |
| Molecular Formula / Molecular Weight | C__1__8H__1__6N__2O__3 = 308.34 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature | Room Temperature (Recommended in a cool and dark place, <15°C) |
| CAS RN | 84088-42-6 |
| Reaxys Registry Number | 8566168 |
| PubChem Substance ID | 354334061 |
| Merck Index (14) | 8259 |
| MDL Number | MFCD00866331 |
Specifications
| Appearance | White to Light yellow powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(Neutralization titration) | min. 96.0 % |
| NMR | confirm to structure |
Properties (reference)
| Melting Point | 204 °C(dec.) |
GHS
| Pictogram |
|
| Signal Word | Warning |
| Hazard Statements | H302 : Harmful if swallowed. |
| Precautionary Statements | P501 : Dispose of contents/ container to an approved waste disposal plant. P270 : Do not eat, drink or smoke when using this product. P264 : Wash skin thoroughly after handling. P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth. |
Related Laws:
Transport Information:
| H.S.code* | 2933.79-000 |
Application
Roquinimex: An Immunostimulant, Angiogenesis Inhibitor and TNF-α Down-Regulator
Linomide (roquinimex, LS 2616) is a synthetic immunostimulant which increases natural killer (NK) cell activity and macrophage cytotoxicity. Linomide also inhibits angiogenesis and reduces the secretion of tumor necrosis factor-α (TNF-α). Linomide has been investigated as an anti-tumor agent and a type I antidiabetes agent. (The product is for research purpose only.)
References
- Treatment of chronic-relapsing experimental autoimmune encephalomyelitis with the synthetic immunomodulator linomide (quinoline-3-carboxamide)
- Linomide inhibits angiogenesis, growth, metastasis, and macrophage infiltration within rat prostatic cancers
- Potentiation of the antiangiogenic ability of Linomide by androgen ablation involves down-regulation of vascular endothelial growth factor in human androgen-responsive prostatic cancers
- Structure-activity relationships studies of the anti-angiogenic activities of linomide
- The immunomodulator Linomide: role in treatment and prevention of autoimmune diabetes mellitus (a review)
- Effects of Linomide on immune cells and cytokines inhibit autoimmune pathologies of the central and peripheral nervous system (a review)
PubMed Literature
Articles/Brochures
TCIMAIL
Product Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.